*These authors contributed equally to the preparation of this manuscript. Cell-based technologies for printing protein microarrays are faced with poor protein expression, protein insolubility, ...

In the post-genomic era, long non-coding RNAs (lncRNAs) have emerged as critical regulators in various cancers and hold potential as minimally invasive diagnostic biomarkers. This study aimed to ...

Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics (BNGO), announced that Centers for Medicare & Medicaid Services, CMS, posted ...

The first study of the use of microarray patches to vaccinate children has shown that the method is safe and induces strong immune responses. The phase 1/2 randomized trial compared results from the ...

All India Institute of Medical Sciences (AIIMS) Jammu has launched Maternal and Fetal Medicine (MFM) services, bringing ...

The phase 1/2 randomized trial compared results from the measles and rubella vaccine delivered by a microarray patch, a small sticking plaster-like device with an array of microscopic projections that ...